Joost van der Mark
Corporate Officer/Principal at BIOSYENT INC.
Net worth: 331 935 $ as of 30/04/2024
Joost van der Mark active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIOSYENT INC. | Corporate Officer/Principal | 10/09/2018 | - |
Career history of Joost van der Mark
Former positions of Joost van der Mark
| Companies | Position | Start | End |
|---|---|---|---|
| TELO GENOMICS CORP. | Corporate Officer/Principal | 06/01/2017 | 31/05/2018 |
| BIOSYENT INC. | Corporate Officer/Principal | 01/08/2015 | 01/01/2017 |
| KNIGHT THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
Orphan Canada, Inc.
 Orphan Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Knight Therapeutics, Inc., Orphan Canada, Inc. is a Canadian company that manufactures specialty pharmaceuticals. The company was founded by Jason Flowerday, Joost van der Mark. Orphan Canada was acquired by Knight Therapeutics, Inc. on September 02, 2014. | Founder | - | - |
| Corporate Officer/Principal | - | - |
Training of Joost van der Mark
| York University | Masters Business Admin |
| University of Western Ontario | Graduate Degree |
| The Schulich School of Business | Masters Business Admin |
Statistics
International
| Canada | 8 |
Operational
| Corporate Officer/Principal | 5 |
| Masters Business Admin | 2 |
| Founder | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BIOSYENT INC. | Health Technology |
| KNIGHT THERAPEUTICS INC. | Health Technology |
| TELO GENOMICS CORP. | Health Services |
| Private companies | 1 |
|---|---|
Orphan Canada, Inc.
Orphan Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Knight Therapeutics, Inc., Orphan Canada, Inc. is a Canadian company that manufactures specialty pharmaceuticals. The company was founded by Jason Flowerday, Joost van der Mark. Orphan Canada was acquired by Knight Therapeutics, Inc. on September 02, 2014. | Health Technology |
- Stock Market
- Insiders
- Joost van der Mark
- Experience
